Development, deployment, and continuous monitoring of a machine learning model to predict respiratory failure in critically ill patients

开发、部署和持续监测用于预测危重患者呼吸衰竭的机器学习模型

阅读:1

Abstract

OBJECTIVES: This study describes the development and deployment of a machine learning (ML) model called Vent.io to predict mechanical ventilation (MV). MATERIALS AND METHODS: We trained Vent.io using electronic health record data of adult patients admitted to the intensive care units (ICUs) of the University of California San Diego (UCSD) Health System. We prospectively deployed Vent.io using a real-time platform at UCSD and evaluated the performance of Vent.io for a 1-month period in silent mode and on the MIMIC-IV dataset. As part of deployment, we included a Predetermined Changed Control Plan (PCCP) for continuous model monitoring that triggers model fine-tuning if performance drops below a specified area under the receiver operating curve (AUC) threshold of 0.85. RESULTS: The Vent.io model had a median AUC of 0.897 (IQR: 0.892-0.904) with specificity of 0.81 (IQR: 0.812-0.841) and positive predictive value (PPV) of 0.174 (IQR: 0.148-0.176) at a fixed sensitivity of 0.6 during 10-fold cross validation and an AUC of 0.908, sensitivity of 0.632, specificity of 0.849, and PPV of 0.235 during prospective deployment. Vent.io had an AUC of 0.73 on the MIMIC-IV dataset, triggering model fine-tuning per the PCCP as the AUC was below the minimum of 0.85. The fine-tuned Vent.io model achieved an AUC of 0.873. DISCUSSION: Deterioration of model performance is a significant challenge when deploying ML models prospectively or at different sites. Implementation of a PCCP can help models adapt to new patterns in data and maintain generalizability. CONCLUSION: Vent.io is a generalizable ML model that has the potential to improve patient care and resource allocation for ICU patients with need for MV.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。